Novelix Pharmaceuticals Limited (BOM:536565)
69.00
-1.05 (-1.50%)
At close: Nov 16, 2026
Novelix Pharmaceuticals Revenue
Novelix Pharmaceuticals had revenue of 447.31M INR in the quarter ending September 30, 2026, with 22.92% growth. This brings the company's total for the last twelve months to 1.55B, up 82.85% year-over-year. In the fiscal year ending March 31, 2026, Novelix Pharmaceuticals had annual revenue of 1.32B with 330.60% growth. That makes Novelix Pharmaceuticals the 34,949th largest company in the world by revenue and 2,846th in India.
Revenue (ttm)
1.55B
Revenue Growth
+82.85%
P/S Ratio
1.28
Revenue / Employee
48.51M
Employees
32
Market Cap
1.96B
Revenue by Segment
- Pharma Business 295.09M 96.0%
- Trading in Shares 12.09M 3.9%
- Finance 159.58K 0.1%
Fiscal year ended Mar 31, 2025 See the full Novelix Pharmaceuticals breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.32B | 1.02B | 330.60% |
| Mar 31, 2025 | 307.33M | 262.02M | 578.26% |
| Mar 31, 2024 | 45.31M | 26.11M | 135.96% |
| Mar 31, 2023 | 19.20M | -69.92M | -78.45% |
| Mar 31, 2022 | 89.13M | -6.72M | -7.01% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chemkart India | 3.17B |
| Rama Vision | 1.95B |
| Chandra Bhagat Pharma | 1.17B |
| VijayPD Ceutical | 1.00B |
| Khemani Distributors & Marketing | 987.34M |
| Aptus Pharma | 811.18M |
| Medistep Healthcare | 731.36M |
| Constronics Infra | 454.43M |